Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Multiple-Station Lymph Node Spread Links to Worse Resected Lung Cancer Survival

4 hours ago 2

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

A systematic review and meta-analysis evaluating the ninth-edition tumor staging framework found that multiple-station pathological N2 involvement is associated with poorer overall survival and worse recurrence outcomes than single-station involvement following curative-intent resection for non-small cell lung cancer. The analysis synthesized published observational cohort data to examine the prognostic distinctions between these two anatomical nodal subgroups in resected disease.

In the ninth edition of the staging system, pathological N2 disease is subdivided into single-station involvement, designated pN2a, and multiple-station involvement, designated pN2b. Although guidelines established this structural division, the magnitude and consistency of differences in survival following surgical resection had remained uncertain across clinical literature, prompting an exhaustive quantitative assessment of post-resection clinical cohorts.

To clarify these survival differences, investigators performed systematic literature searches across five major electronic databases: PubMed/MEDLINE, Embase, the Web of Science Core Collection, Scopus, and the Cochrane Library. The database queries specifically covered studies published from January 1, 2023, through October 6, 2026. The researchers systematically evaluated the potential risk of bias across all eligible cohort studies using the Quality In Prognosis Studies assessment tool.

Study eligibility criteria restricted the meta-analysis to clinical cohorts comparing station-defined pN2b with pN2a disease in adult patients diagnosed with non-metastatic M0 non-small cell lung cancer who had pathologically confirmed N2 involvement following curative-intent surgical resection. Across the retrieved medical literature, ten retrospective cohorts met all required inclusion criteria, contributing 3,809 total patients, comprising 2,310 individuals with pN2a disease and 1,499 individuals with pN2b disease.

The primary endpoint was overall survival, while secondary endpoints included recurrence-free survival, disease-free survival, and freedom from recurrence. Hazard ratios were pooled using random-effects inverse-variance models. In the primary overall survival analysis, four studies contributed multivariable-adjusted hazard ratios, demonstrating poorer survival with pN2b, with a pooled hazard ratio of 1.58, a 95 percent confidence interval of 1.40 to 1.77, and an I-squared value of 0 percent.

An analysis incorporating all eight studies reporting overall survival yielded a similar association, showing a pooled hazard ratio of 1.50 with a 95 percent confidence interval from 1.37 to 1.65 and an I-squared value of 0 percent. Secondary recurrence outcomes also favored single-station disease, with pooled hazard ratios of 1.49 across five studies for recurrence-free survival, 1.39 across two studies for disease-free survival, and 1.70 across two studies for freedom from recurrence.

Subject of Research: Prognostic impact of ninth-edition pathological N2a and N2b lymph node subclassification in resected non-small cell lung cancer

Article Title: Association of the ninth-edition pathological N2a/N2b subclassification with survival in resected non-small cell lung cancer: A systematic review and meta-analysis

Article References: Ruan, Y., Cao, W., Long, C., Han, J., & Zhang, T. (2026). Association of the ninth-edition pathological N2a/N2b subclassification with survival in resected non-small cell lung cancer: A systematic review and meta-analysis. BMC Cancer. https://doi.org/10.1186/s12885-026-17440-x

Image Credits: AI Generated

DOI: 10.1186/s12885-026-17440-x

Keywords: non-small cell lung cancer, pathological N2 disease, pN2a subclassification, pN2b subclassification, TNM staging ninth edition, curative-intent resection, overall survival, recurrence-free survival, disease-free survival, freedom from recurrence, systematic review, meta-analysis, Quality In Prognosis Studies, random-effects models, lymph node stations, prognostic discrimination

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway